Superior vena cava isolation using a pentaspline pulsed-field ablation catheter: feasibility and safety in patients undergoing atrial fibrillation catheter ablation

Pierre Ollitrault; Corentin Chaumont; Jonaz Font; Martin Manninger; Sergio Conti; Paweł T Matusik; Bart A Mulder; Virginie Ferchaud; Arnaud Pellissier; Mayane Al Khoury; Paul Milliez; Laure Champ-Rigot; Frédéric Anselme

doi:10.1093/europace/euae160

Superior vena cava isolation using a pentaspline pulsed-field ablation catheter: feasibility and safety in patients undergoing atrial fibrillation catheter ablation

Pierre Ollitrault^*, Corentin Chaumont, Jonaz Font, Martin Manninger, Sergio Conti, Paweł T Matusik, Bart A Mulder, Virginie Ferchaud, Arnaud Pellissier, Mayane Al Khoury, Paul Milliez, Laure Champ-Rigot, Frédéric Anselme

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

10 Citations (Scopus)

11 Downloads (Pure)

Abstract

AIMS: Superior vena cava (SVC) isolation during atrial fibrillation catheter ablation is limited by the risk of collateral damage to the sinus node and/or the phrenic nerve. Due to its tissue-specificity, we hypothesized the feasibility and safety of pulsed-field ablation (PFA)-based SVC isolation.

METHODS AND RESULTS: One hundred and five consecutive patients undergoing PFA-based AF catheter ablation were prospectively included. After pulmonary vein isolation (±posterior wall isolation and electrical cardioversion), SVC isolation was performed using a standardized workflow. Acute SVC isolation was achieved in 105/105 (100%) patients after 6 ± 1 applications. Transient phrenic nerve stunning occurred in 67/105 (64%) patients but without phrenic nerve palsy at the end of the procedure and at hospital discharge. Transient high-degree sinus node dysfunction occurred in 5/105 (4.7%) patients, with no recurrence at the end of the procedure and until discharge. At the 3-month follow-up visit, no complication occurred.

CONCLUSION: SVC isolation using a pentaspline PFA catheter is feasible and safe.

Original language	English
Article number	euae160
Number of pages	7
Journal	EP Europace
Volume	26
Issue number	7
DOIs	https://doi.org/10.1093/europace/euae160
Publication status	Published - 2-Jul-2024

Keywords

Humans
Atrial Fibrillation/surgery
Catheter Ablation/methods
Male
Female
Feasibility Studies
Vena Cava, Superior/surgery
Middle Aged
Aged
Treatment Outcome
Prospective Studies
Pulmonary Veins/surgery
Cardiac Catheters
Equipment Design
Phrenic Nerve/injuries

Access to Document

10.1093/europace/euae160Licence: CC BY

Superior vena cava isolation using a pentaspline pulsed-field ablation catheterFinal publisher's version, 7.73 MBLicence: CC BY

Handle.net

Persistent link

Cite this

Ollitrault, P., Chaumont, C., Font, J., Manninger, M., Conti, S., Matusik, P. T., Mulder, B. A., Ferchaud, V., Pellissier, A., Al Khoury, M., Milliez, P., Champ-Rigot, L., & Anselme, F. (2024). Superior vena cava isolation using a pentaspline pulsed-field ablation catheter: feasibility and safety in patients undergoing atrial fibrillation catheter ablation. EP Europace, 26(7), Article euae160. https://doi.org/10.1093/europace/euae160

@article{2abbab03fbfc466497da8d95733bb40c,

title = "Superior vena cava isolation using a pentaspline pulsed-field ablation catheter: feasibility and safety in patients undergoing atrial fibrillation catheter ablation",

abstract = "AIMS: Superior vena cava (SVC) isolation during atrial fibrillation catheter ablation is limited by the risk of collateral damage to the sinus node and/or the phrenic nerve. Due to its tissue-specificity, we hypothesized the feasibility and safety of pulsed-field ablation (PFA)-based SVC isolation.METHODS AND RESULTS: One hundred and five consecutive patients undergoing PFA-based AF catheter ablation were prospectively included. After pulmonary vein isolation (±posterior wall isolation and electrical cardioversion), SVC isolation was performed using a standardized workflow. Acute SVC isolation was achieved in 105/105 (100%) patients after 6 ± 1 applications. Transient phrenic nerve stunning occurred in 67/105 (64%) patients but without phrenic nerve palsy at the end of the procedure and at hospital discharge. Transient high-degree sinus node dysfunction occurred in 5/105 (4.7%) patients, with no recurrence at the end of the procedure and until discharge. At the 3-month follow-up visit, no complication occurred.CONCLUSION: SVC isolation using a pentaspline PFA catheter is feasible and safe.",

keywords = "Humans, Atrial Fibrillation/surgery, Catheter Ablation/methods, Male, Female, Feasibility Studies, Vena Cava, Superior/surgery, Middle Aged, Aged, Treatment Outcome, Prospective Studies, Pulmonary Veins/surgery, Cardiac Catheters, Equipment Design, Phrenic Nerve/injuries",

author = "Pierre Ollitrault and Corentin Chaumont and Jonaz Font and Martin Manninger and Sergio Conti and Matusik, {Pawe{\l} T} and Mulder, {Bart A} and Virginie Ferchaud and Arnaud Pellissier and {Al Khoury}, Mayane and Paul Milliez and Laure Champ-Rigot and Fr{\'e}d{\'e}ric Anselme",

note = "{\textcopyright} The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.",

year = "2024",

month = jul,

day = "2",

doi = "10.1093/europace/euae160",

language = "English",

volume = "26",

journal = "EP Europace",

issn = "1099-5129",

publisher = "Oxford University Press",

number = "7",

}

Ollitrault, P, Chaumont, C, Font, J, Manninger, M, Conti, S, Matusik, PT, Mulder, BA, Ferchaud, V, Pellissier, A, Al Khoury, M, Milliez, P, Champ-Rigot, L & Anselme, F 2024, 'Superior vena cava isolation using a pentaspline pulsed-field ablation catheter: feasibility and safety in patients undergoing atrial fibrillation catheter ablation', EP Europace, vol. 26, no. 7, euae160. https://doi.org/10.1093/europace/euae160

TY - JOUR

T1 - Superior vena cava isolation using a pentaspline pulsed-field ablation catheter

T2 - feasibility and safety in patients undergoing atrial fibrillation catheter ablation

AU - Ollitrault, Pierre

AU - Chaumont, Corentin

AU - Font, Jonaz

AU - Manninger, Martin

AU - Conti, Sergio

AU - Matusik, Paweł T

AU - Mulder, Bart A

AU - Ferchaud, Virginie

AU - Pellissier, Arnaud

AU - Al Khoury, Mayane

AU - Milliez, Paul

AU - Champ-Rigot, Laure

AU - Anselme, Frédéric

N1 - © The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.

PY - 2024/7/2

Y1 - 2024/7/2

N2 - AIMS: Superior vena cava (SVC) isolation during atrial fibrillation catheter ablation is limited by the risk of collateral damage to the sinus node and/or the phrenic nerve. Due to its tissue-specificity, we hypothesized the feasibility and safety of pulsed-field ablation (PFA)-based SVC isolation.METHODS AND RESULTS: One hundred and five consecutive patients undergoing PFA-based AF catheter ablation were prospectively included. After pulmonary vein isolation (±posterior wall isolation and electrical cardioversion), SVC isolation was performed using a standardized workflow. Acute SVC isolation was achieved in 105/105 (100%) patients after 6 ± 1 applications. Transient phrenic nerve stunning occurred in 67/105 (64%) patients but without phrenic nerve palsy at the end of the procedure and at hospital discharge. Transient high-degree sinus node dysfunction occurred in 5/105 (4.7%) patients, with no recurrence at the end of the procedure and until discharge. At the 3-month follow-up visit, no complication occurred.CONCLUSION: SVC isolation using a pentaspline PFA catheter is feasible and safe.

AB - AIMS: Superior vena cava (SVC) isolation during atrial fibrillation catheter ablation is limited by the risk of collateral damage to the sinus node and/or the phrenic nerve. Due to its tissue-specificity, we hypothesized the feasibility and safety of pulsed-field ablation (PFA)-based SVC isolation.METHODS AND RESULTS: One hundred and five consecutive patients undergoing PFA-based AF catheter ablation were prospectively included. After pulmonary vein isolation (±posterior wall isolation and electrical cardioversion), SVC isolation was performed using a standardized workflow. Acute SVC isolation was achieved in 105/105 (100%) patients after 6 ± 1 applications. Transient phrenic nerve stunning occurred in 67/105 (64%) patients but without phrenic nerve palsy at the end of the procedure and at hospital discharge. Transient high-degree sinus node dysfunction occurred in 5/105 (4.7%) patients, with no recurrence at the end of the procedure and until discharge. At the 3-month follow-up visit, no complication occurred.CONCLUSION: SVC isolation using a pentaspline PFA catheter is feasible and safe.

KW - Humans

KW - Atrial Fibrillation/surgery

KW - Catheter Ablation/methods

KW - Male

KW - Female

KW - Feasibility Studies

KW - Vena Cava, Superior/surgery

KW - Middle Aged

KW - Aged

KW - Treatment Outcome

KW - Prospective Studies

KW - Pulmonary Veins/surgery

KW - Cardiac Catheters

KW - Equipment Design

KW - Phrenic Nerve/injuries

U2 - 10.1093/europace/euae160

DO - 10.1093/europace/euae160

M3 - Article

C2 - 38875490

SN - 1099-5129

VL - 26

JO - EP Europace

JF - EP Europace

IS - 7

M1 - euae160

ER -

Superior vena cava isolation using a pentaspline pulsed-field ablation catheter: feasibility and safety in patients undergoing atrial fibrillation catheter ablation

Abstract

Keywords

Access to Document

Handle.net

Fingerprint

Cite this